ProQR Therapeutics (PRQR) Exchange Rate Effect (2014 - 2026)
ProQR Therapeutics (PRQR) posted Exchange Rate Effect of $337174.7 for Q1 2026, up 2313.82% sequentially from $13968.5 in Q4 2025, and up 167.91% YoY from $125852.9 in Q1 2025.
Analysis
ProQR Therapeutics (PRQR) Exchange Rate Effect (2014 - 2026) Analysis & Trends
ProQR Therapeutics has reported Exchange Rate Effect for 13 years, with the latest figure at $337174.7 in Q1 2026.
- Quarterly Exchange Rate Effect rose 167.91% year-over-year to $337174.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$655298.2 (down 560.85% YoY) and the FY2025 annual result came in at -$1.6 million, down 318.19% from the prior year.
- Exchange Rate Effect climbed to $337174.7 in Q1 2026 per PRQR's latest filing, from $13968.5 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $4.5 million in Q2 2022 and troughed at -$1.6 million in Q4 2022.
- A 5-year average of $471497.3 and a median of $66767.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect soared 432.46% in 2024, then sank 1547.86% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$1.6 million in 2022, then surged by 86.01% to -$229175.2 in 2023, then jumped by 432.46% to $761908.5 in 2024, then tumbled by 98.17% to $13968.5 in 2025, then soared by 2313.82% to $337174.7 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $337174.7, $13968.5, and -$39747.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - | 20,922.51 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,922.51 |
| Mar 31, 2026 | 337,174.75 |
| Dec 31, 2025 | 13,968.52 |
| Sep 30, 2025 | -39,747.87 |
| Jun 30, 2025 | -966,693.57 |
| Mar 31, 2025 | -496,489.46 |
| Dec 31, 2024 | 761,908.52 |
| Sep 30, 2024 | -189,991.97 |
| Jun 30, 2024 | 66,767.03 |
| Mar 31, 2024 | 77,131.69 |
| Dec 31, 2023 | -229,175.20 |
| Sep 30, 2023 | 128,453.68 |
| Jun 30, 2023 | 936,474.98 |
| Mar 31, 2023 | -178,174.74 |
| Dec 31, 2022 | -1.64 Mn |
| Sep 30, 2022 | 3.42 Mn |
| Jun 30, 2022 | 4.51 Mn |
| Mar 31, 2022 | 1.51 Mn |
| Dec 31, 2021 | 938,056.18 |
| Sep 30, 2021 | 1.61 Mn |